Stephen Gilbride founded SG Research International (SGRI), a Pharmaceutical Quality Assurance Consulting Firm in 2006 with offices in Wyckoff, NJ and now in Beijing, China. SGRI has a keen focus on GCP Quality Assurance as it relates to clinical trials as well as managing Corrective and Preventive Actions (CAPA). SGRI has developed a QA group of trusted and experienced regionally-based colleagues who are positioned globally to leverage their broad range of experience to reduce risk in clinical trials. SGRI has acted as Quality Head for a successful Biotech Company in 2011. SGRI has been successful in embedding Quality in Clinical Operations for several pharmaceutical companies.